86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03554291 (ClinicalTrials.gov)	May 1, 2019	31/5/2018	Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension	Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension	Pulmonary Arterial Hypertension;Right Heart Failure	Drug: Famotidine 20 MG;Other: Placebo	University of Washington	National Heart, Lung, and Blood Institute (NHLBI)	Recruiting	18 Years	80 Years	All	80	Phase 2	United States

First Previous1Next Last